Spearhead strategic vision and operational execution for a leading Aesthetic organization, focusing on growth and innovation.Foster an inclusive company culture that emphasizes collaboration, accountability, and high performance among team members.Lead initiatives that have significantly enhanced the innovative product development and strategic partnerships.

I am a dedicated start-up specialist in the life sciences sector, guiding companies from the idea phase through the complete development cycle to successful commercialization. My expertise encompasses securing funding and navigating the complexities of financial rounds, ensuring that innovative ideas transform into market-ready products.As a business consultant, I focus on business development, strategic planning, and market introduction of medical devices, diagnostic kits, and drug delivery products. I collaborate closely with founders to set the right direction for product development, patent strategy, and business models. My strong emphasis on team development ensures rapid and sustainable market entry, with processes in place to execute project and development plans effectively.With a proven ability to negotiate complex deals, I help founders and management teams secure essential financing and customer contracts. My clients operate within the healthcare industry, including companies that develop, manufacture, and sell medical devices, pharmaceuticals, and biotechnology products.I leverage a multidisciplinary approach to R&D and technology, working across various fields to address unmet clinical needs and tailor solutions to meet specific technological demands. My primary focus lies in intellectual property (patents and licenses) and technology development, generating revenue through licensing and application development services.- Key Expertise:- Start-up Operations- Fast-Paced Product Development- Complex Deal Structures- Licensing-In and Licensing-Out- Sales and Marketing Strategy- Business Development and General Management- Drug Delivery Systems- Biomaterials and Medical Devices- Pharmaceuticals and Biotechnology- Strategy Development and Implementation

www.materiomics.comMATERIOMICS makes pharma, drug development and toxicology faster, more reliable and more successful -replacing animal tests- with the revolutionary family of ACE organ test models (liver, colon, heart) featuring our proprietary surface topographies.Surface structure, next to chemical composition, direct interaction between (medical) devices and (human) cells. Based on this concept -cell behavior is guided by surface structure- MATERIOMICS designs algorithm-based unique surface topographies to improve the performance of cell culture ware and medical devices.

20Med Therapeutics is a Dutch start-up biomedical company active in the field of controlled drug delivery, developing and exploiting a portfolio of multifunctional polymer-based carriers for targeted delivery of small interfering RNAs (siRNAs) and microRNAs (miRNAs) for treatment of genetic diseases.The founding of 20MED is based on the recent discovery in the Biomedical Chemistry labs of the University of Twente of an innovative and a unique type of polymeric hybrid constructs (20MED-nanogels) that possess a hitherto unmet combination of properties which are essential for successful siRNA delivery in clinical applications. Due to their special chemical construction 20Med-nanogels are stable, well processable, nontoxic nanoparticles that can be easily loaded with therapeutic small RNAs, and specific chemical functionalities within the 20MED-nanogel architecture promote the efficient release of the therapeutic payload once the nanoparticles are taken up by the cells, resulting in high transfection and gene silencing efficiencies.The superior properties of 20MED-nanogels above current siRNA delivery systems have been demonstrated in in-vitro and in-vivo experiments. The company’s mission on the short term is to further develop and expand this proprietary set of unique polymeric hybrid constructs for RNAi application in a diversity of gene related diseases, and demonstrate their great potential for safe and efficient siRNA and miRNA based gene therapy in a clinical setting. 20Med therapeutics will establish cooperation with biotech and pharma companies that are addressing specific genetic diseases to meet their (currently almost always) existing need for improved gene carrier systems for in vivo application.

Encapson is a dynamic, technology-driven company specializing in innovative coatings for medical devices.Our exciting new coating Sono-Coat is an echogenic coating which can be used to make a medical device more visible in a patient under ultrasound. It can be used to coat many different types of devices from steel needles to polymer based catheters. The advantage of Sono-Coat over other methods of enhancing Ultrasound visibility is that it can be tailored to the needs of the device. It can be applied only as a marker, or can be used to coat the whole device or it can be used as a primer with a second lubricious, or insulating coating over the top. Sono-coat is an excellent way to add a great feature to a medical device to give it an edge over the competition.